AXSM — AXSOME THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.43% (2025 Q4)
Avg. % of fund
0.12%
First filed
2022 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 149,392 +105,242 +238.4% 0.43% $27.3M $182.64
2025 Q3 ADDED 44,150 +6,720 +18.0% 0.09% $5.4M $121.45
2025 Q2 ADDED 37,430 +11,490 +44.3% 0.08% $3.9M $104.39
2025 Q1 ADDED 25,940 +22,835 +735.4% 0.07% $3.0M $116.63
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AXSM price (monthly, adj. close)

Other funds also holding AXSM

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 59.3% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 4.96% Tri Locum Partners LP 3Y 4.78% PFM Health Sciences, LP 3Y 7Y 4.58% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.52% First Turn Management, LLC 4.32% Deep Track Capital, LP 3Y 3.74% SUPERSTRING CAPITAL MANAGEMENT LP 3.66% Rhenman & Partners Asset Management AB 3Y 7Y 1.96% Privium Fund Management B.V. 3Y 1.91%
← Back to ALGERT GLOBAL LLC Holdings